NCT02106598View on ClinicalTrials.gov

Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 3, 2014

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Head and Neck Melanoma
Interventions
DRUG

fluorescent cRGDY-PEG-Cy5.5-C dots

Trial Locations (2)

10065

Memorial Sloan Kettering Cancer Center, New York

Unknown

Weill Cornell Medical Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02106598 - Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases | Biotech Hunter | Biotech Hunter